Cargando…
Clinician attitudes towards cancer treatment guidelines in Australia
OBJECTIVES: Clinical Practice Guidelines (CPGs) are designed to guide treatment decisions, yet adherence rates vary widely. To characterise perceived barriers and facilitators to cancer treatment CPG adherence in Australia, and estimate the frequency of previous qualitative research findings, a surv...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188226/ https://www.ncbi.nlm.nih.gov/pubmed/37194072 http://dx.doi.org/10.1186/s13104-023-06356-5 |
_version_ | 1785042872207147008 |
---|---|
author | Bierbaum, Mia Arnolda, Gaston Braithwaite, Jeffrey Rapport, Frances |
author_facet | Bierbaum, Mia Arnolda, Gaston Braithwaite, Jeffrey Rapport, Frances |
author_sort | Bierbaum, Mia |
collection | PubMed |
description | OBJECTIVES: Clinical Practice Guidelines (CPGs) are designed to guide treatment decisions, yet adherence rates vary widely. To characterise perceived barriers and facilitators to cancer treatment CPG adherence in Australia, and estimate the frequency of previous qualitative research findings, a survey was distributed to Australian oncologists. RESULTS: The sample is described and validated guideline attitude scores reported for different groups. Differences in mean CPG attitude scores across clinician subgroups and associations between frequency of CPG use and clinician characteristics were calculated; with 48 respondents there was limited statistical power to find differences. Younger oncologists (< 50 years) and clinicians participating in three or more Multidisciplinary Team Meetings were more likely to routinely or occasionally use CPGs. Perceived barriers and facilitators were identified. Thematic analysis was conducted on open-text responses. Results were integrated with previous interview findings and presented in a thematic, conceptual matrix. Most barriers and facilitators identified earlier were corroborated by survey results, with minor discordance. Identified barriers and facilitators require further exploration within a larger sample to assess their perceived impact on cancer treatment CPG adherence in Australia, as well as to inform future CPG implementation strategies. This research was Human Research Ethics Committee approved (2019/ETH11722 and 52019568810127, ID:5688). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13104-023-06356-5. |
format | Online Article Text |
id | pubmed-10188226 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101882262023-05-17 Clinician attitudes towards cancer treatment guidelines in Australia Bierbaum, Mia Arnolda, Gaston Braithwaite, Jeffrey Rapport, Frances BMC Res Notes Research Note OBJECTIVES: Clinical Practice Guidelines (CPGs) are designed to guide treatment decisions, yet adherence rates vary widely. To characterise perceived barriers and facilitators to cancer treatment CPG adherence in Australia, and estimate the frequency of previous qualitative research findings, a survey was distributed to Australian oncologists. RESULTS: The sample is described and validated guideline attitude scores reported for different groups. Differences in mean CPG attitude scores across clinician subgroups and associations between frequency of CPG use and clinician characteristics were calculated; with 48 respondents there was limited statistical power to find differences. Younger oncologists (< 50 years) and clinicians participating in three or more Multidisciplinary Team Meetings were more likely to routinely or occasionally use CPGs. Perceived barriers and facilitators were identified. Thematic analysis was conducted on open-text responses. Results were integrated with previous interview findings and presented in a thematic, conceptual matrix. Most barriers and facilitators identified earlier were corroborated by survey results, with minor discordance. Identified barriers and facilitators require further exploration within a larger sample to assess their perceived impact on cancer treatment CPG adherence in Australia, as well as to inform future CPG implementation strategies. This research was Human Research Ethics Committee approved (2019/ETH11722 and 52019568810127, ID:5688). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13104-023-06356-5. BioMed Central 2023-05-16 /pmc/articles/PMC10188226/ /pubmed/37194072 http://dx.doi.org/10.1186/s13104-023-06356-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Note Bierbaum, Mia Arnolda, Gaston Braithwaite, Jeffrey Rapport, Frances Clinician attitudes towards cancer treatment guidelines in Australia |
title | Clinician attitudes towards cancer treatment guidelines in Australia |
title_full | Clinician attitudes towards cancer treatment guidelines in Australia |
title_fullStr | Clinician attitudes towards cancer treatment guidelines in Australia |
title_full_unstemmed | Clinician attitudes towards cancer treatment guidelines in Australia |
title_short | Clinician attitudes towards cancer treatment guidelines in Australia |
title_sort | clinician attitudes towards cancer treatment guidelines in australia |
topic | Research Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188226/ https://www.ncbi.nlm.nih.gov/pubmed/37194072 http://dx.doi.org/10.1186/s13104-023-06356-5 |
work_keys_str_mv | AT bierbaummia clinicianattitudestowardscancertreatmentguidelinesinaustralia AT arnoldagaston clinicianattitudestowardscancertreatmentguidelinesinaustralia AT braithwaitejeffrey clinicianattitudestowardscancertreatmentguidelinesinaustralia AT rapportfrances clinicianattitudestowardscancertreatmentguidelinesinaustralia |